The Food and Drug Administration says it has approved a
first-of-a-kind diabetes drug from Johnson & Johnson that uses a new
method to lower blood sugar.
The agency cleared J&J's Invokana tablets for adults with Type 2
diabetes, which affects about 26 million Americans.
The drug is a once-a-day medicine designed to lower blood sugar levels
in patients by eliminating more sugarin their urine. The drug works by
blocking the reabsorption of sugar by the kidneys, which occurs at
higher levels in patients with diabetes.
J&J has touted the drug as the first in anew class of medications to
help address the nation's growing diabetes epidemic. The drug differs
from older drugs that work by decreasing the amount of sugar absorbed
from food and stored in the liver.
No comments:
Post a Comment
What Do You Think?...